Pharmafile.com’s weekly COVID-19 news round-up
pharmafile | July 22, 2020 | News story | Research and Development |Â Â COVID-19, coronavirusÂ
The COVID-19 news this week once again focuses on vaccines, as the UK has secured early access to 90 million doses of coronavirus vaccines through multiple partnerships with pharmaceutical companies, while the first COVID-19 vaccine being used in clinical trials in the US is set to begin final testing.
In other news, an Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus 3 months after recovering from it, while the Trump administration has ordered hospitals to stop sending coronavirus patient data to the Centers for Disease Control and Prevention (CDC) and instead to a central database in Washington, DC.
1. Trump administration orders hospitals to stop sending COVID-19 data to the CDC – Published on 16/07/20
The Trump administration has ordered hospitals to stop sending coronavirus patient data to the Centers for Disease Control and Prevention (CDC) and instead to a central database in Washington, DC.
2. Moderna’s COVID-19 vaccine candidate set for final testing in the US – Published on 15/07/20
The first COVID-19 vaccine being used in clinical trials in the US is set to begin final testing.
3. Israeli doctor tests positive for coronavirus 3 months after recovering – Published on 20/07/20
An Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus 3 months after recovering from it.
4. UK secures early access to 90 million doses of coronavirus vaccines – Published on 20/07/20
The UK has secured early access to 90 million doses of coronavirus vaccines through multiple partnerships with pharmaceutical companies.
5. Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data show – Published on 20/07/20
Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company has just revealed promising data on the interferon beta-based therapy, known as SNG001, in the treatment of patients hospitalised with the disease.
Related Content
COVID-19 vaccine eligibility creates challenges for UK pharmacies
Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments …
Mental health medicine use in England reaches record high, NHSBSA report reveals
According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions …
FDA approves Moderna’s Spikevax for children at increased risk of COVID-19
Moderna has been granted US Food and Drug Administration (FDA) approval for its COVID-19 vaccine, …
